How much is apiject worth?
ApiJect Announces Investment $111 Million Equity Investment Round by Royalty Pharma and Jefferies. This investment round values ApiJect at approximately $300 million. The new round was led by Royalty Pharma and Jefferies Financial Group (NYSE: JEF), which acquired a revenue interest in addition to equity.
What is apiject and who owns it?
Who owns ApiJect? According to its website, ApiJect’s mission is “to make injectable medicine safe and available for everyone.” The company is privately owned and based in Connecticut. It was founded by Marc Koska, "who was made an Officer of the Order of the British Empire for his earlier work in injection safety."
Why choose and apiject?
And ApiJect is working with leading contract manufacturers to provide additional capacity to serve pharmaceutical partners that prefer outside manufacturing services. INTERPHEX Live offers prerecorded interviews and discussion on the latest, cutting-edge pharmaceutical and biopharmaceutical technologies.
What's new at apiject?
New Facility Brings to the U.S. Critical Capabilities for the Design, Engineering and Testing of ApiJect's High Volume Manufacturing Process for Making Single-Dose, Prefilled Syringes.
How much did ApiJect get awarded?
ApiJect Systems America has garnered significant media attention after NBC reported on Apr. 21 that the medical technology company had been awarded $1.3 billion to make syringes for COVID-19 vaccines.
What is ApiJect Systems?
positioned itself as the company that would make the difference between a stumbling rollout and delivery of lifesaving vaccines.”
How much money did ApiJect get from the Department of Defense?
There is no public valuation information available on ApiJect. The company said it had received $138 million in contracts from the Department of Defense and up to $13 million from HHS.
Does ApiJect have inventory?
Therefore, the syringes are not missing, claims ApiJect. The company also stated that it has an on-demand manufacturing system and does not have inventory. This differs from typical syringe manufacturing because the “prefilled syringes are made and filled in one step as needed.”. Article continues below advertisement.
Is ApiJect publicly traded?
ApiJect is not publicly traded on the stock market, so you can’t invest in the company at this time. It has not disclosed whether it intends to go public, either. Advertisement.
Is ApiJect in compliance with the FDA?
Both HHS and the Pentagon have said ApiJect is in full compliance with the terms of their contracts. According to ApiJect, it has packaged two of the COVID-19 vaccines so that vaccine companies can test their product with its syringe technology and then seek approval from the FDA.
